Viewing Study NCT01942135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:42 PM
Ignite Modification Date: 2026-01-15 @ 6:09 PM
Study NCT ID: NCT01942135
Status: COMPLETED
Last Update Posted: 2024-04-04
First Post: 2013-09-10
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Palbociclib (PD-0332991) View
None Fulvestrant View
None Goserelin View
None Hormone receptor-+ View
None HER2-negative View
None Prior Endocrine treatment View
None any menopausal status View
None PALOMA-3 View